Report No. 3/2026 Admission and conditional introduction of the Company’s ordinary bearer shares of series O to trading on the WSE Main Market

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A., with its registered office in Wrocław (the “Company”), hereby announces that today it became aware that on 9 January 2026 the Management Board of the Warsaw Stock Exchange S.A. (the “WSE”) adopted Resolution No. 18/2026 on the admission and introduction to exchange trading on the WSE Main […]

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.